Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Takeda Pharmaceutical Co Ltd

+ Add to Watchlist

4502:JP

6,108.0 JPY 0.00.00%

As of 01:00:00 ET on 02/26/2015.

Snapshot for Takeda Pharmaceutical Co Ltd (4502)

Open: - Day's Range: - Volume: 1,678,400
Previous Close: 6,108.0 52wk Range: 4,337.5 - 6,166.0 1-Yr Rtn: +30.08%

Stock Chart for 4502

No chart data available.
  • 4502:JP 6,106.0
  • 1D
  • 1M
  • 1Y
6,108.0
Interactive 4502 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4502

Current P/E Ratio (ttm) 81.2018
Estimated P/E(03/2015) 36.3792
Relative P/E vs. TPX 4.6860
Earnings Per Share (JPY) (ttm) 75.2200
Est. EPS (JPY) (03/2015) 167.8980
Est. PEG Ratio 3.2052
Market Cap (M JPY) 4,824,305.43
Shares Outstanding (M) 789.83
30 Day Average Volume 3,153,923
Price/Book (mrq) 1.9171
Price/Sale (ttm) 2.7550
Dividend Indicated Gross Yield 2.95%
Cash Dividend (JPY) 90.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -0.22%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4502

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4502

Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.

Yasuchika HasegawaChief Executive OfficerChristophe WeberPresident/COO
Francois-Xavier RogerChief Financial OfficerShinji HondaSenior Managing Director
More Company Profile & Key Executives for 4502

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil